Water → HCID 10286449, Verbindung

HRID 985079Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 985079
[OH:1][CH:2]1[C:11](=[O:12])[C:10]2[CH:9]=[CH:8][N:7]3[C:13]([CH3:17])=[C:14]([CH3:16])[N:15]=[C:6]3[C:5]=2[NH:4][CH:3]1[C:18]1[CH:22]=[CH:21][S:20][CH:19]=1.[BH4-].[Na+].O.C(=O)([O-])O.[Na+]>CO.Cl>[OH:12][CH:11]1[C:10]2[CH:9]=[CH:8][N:7]3[C:13]([CH3:17])=[C:14]([CH3:16])[N:15]=[C:6]3[C:5]=2[NH:4][CH:3]([C:18]2[CH:22]=[CH:21][S:20][CH:19]=2)[CH:2]1[OH:1]

Komponenten

7

Versuchsvorschrift

50 mg of 8-hydroxy-2,3-dimethyl-9-(3-thienyl)-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-7-one are suspended in 5 ml of methanol and treated with 100 mg of sodium borohydride at room temperature with vigorous stirring. After stirring at room temperature for 1 hour, the solvent is stripped off in vacuo, the residue is covered with a layer of 5 ml of water, the mixture is adjusted to pH 1 with a few drops of semisaturated aqueous hydrochloric acid and then adjusted to pH 8 using saturated aqueous sodium hydrogen carbonate solution, extracted three times with 20 ml of methylene chloride each time, the combined organic phases are concentrated to dryness in vacuo and the remaining solid residue is purified on silica gel (eluent: methylene chloride/methanol=13/1). 45 mg of the title compound of m.p. 134-38° C. are obtained.

Aufarbeitung

  1. extractionextracted three times with 20 ml of methylene chloride each time
  2. concentrationthe combined organic phases are concentrated to dryness in vacuo
  3. customthe remaining solid residue is purified on silica gel (eluent: methylene chloride/methanol=13/1)

Quellen und Nachweise

ORD-Eintrag
ord-002ec1a151414d499fc328aee8d0da72
Quelldatensatz
uspto-grants-2005_03
Patentnummer
US06869949B2

Notizen zur Reaktion

Wird geladen…